Joint Stock Company Pharmstandard
Joint Stock Company Pharmstandard, headquartered in Russia, is a leading player in the pharmaceutical industry, specialising in the development, production, and distribution of a wide range of medicinal products. Founded in 2003, the company has established itself as a key provider of high-quality pharmaceuticals, with a strong presence in major operational regions across Russia and the CIS. Pharmstandard's core offerings include prescription medications, over-the-counter drugs, and biopharmaceuticals, distinguished by their commitment to innovation and quality. The company has achieved significant milestones, including the introduction of several unique formulations that cater to diverse therapeutic areas. With a robust market position, Pharmstandard is recognised for its contributions to healthcare, making it a trusted name among healthcare professionals and patients alike.
DitchCarbon Score
How does Joint Stock Company Pharmstandard's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Joint Stock Company Pharmstandard's score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Joint Stock Company Pharmstandard's reported carbon emissions
Joint Stock Company Pharmstandard, headquartered in Russia, currently does not have available data on carbon emissions or specific climate commitments. As such, there are no reported figures regarding their Scope 1, 2, or 3 emissions, nor any established reduction targets or initiatives. In the absence of concrete emissions data, it is unclear how the company is addressing climate change or contributing to sustainability efforts within the pharmaceutical industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Joint Stock Company Pharmstandard is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
